AAFA Raises Alarm on MFN Drug Pricing Policy, Cites Risk to Patient Access

The Asthma and Allergy Foundation of America (AAFA) appreciates the President’s Executive Order calling attention to America’s persistent pro...

May 16, 2025 | Friday | News
Invivyd Urges FDA to Modernize COVID-19 Vaccine Evaluation Through Citizen Petition

Invivyd, Inc. announced it has submitted a Citizen Petition with the U.S. Food and Drug Administration (FDA) calling on the Agency to evolve from histori...

May 15, 2025 | Thursday | News
Silo Pharma Engages Veloxity Labs to Advance IND-Enabling Study for PTSD Treatment Candidate SPC-15

Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems,  announced that it has e...

May 15, 2025 | Thursday | News
Ecolab Opens Bioprocessing Applications Lab in Eastern U.S. to Boost Biotherapeutic Purification Support

  The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecu...

May 15, 2025 | Thursday | News
Illumina Unveils DRAGEN™ v4.4 with Breakthrough Accuracy and Oncology-Ready Applications

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling ...

May 14, 2025 | Wednesday | News
CellFE and Made Scientific Partner to Validate Scalable Non-Viral Gene Editing for T Cell Therapies

CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization...

May 14, 2025 | Wednesday | News
Azenta’s GENEWIZ and Form Bio Partner to Accelerate AAV Gene Therapy Development with Integrated Sequencing and AI Analysis

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. Azenta, Inc.a...

May 14, 2025 | Wednesday | News
Invenra Launches T-Body™ Trispecific Antibody Platform to Advance Next-Gen Multispecific Therapeutics

Invenra Inc., a pioneer in multispecific antibody discovery and development, announces the launch of its T-Body™ trispecific antibody platform, a n...

May 14, 2025 | Wednesday | News
OmniAb Showcases xPloration Platform at PEGS Boston to Transform Antibody Discovery with AI-Powered Single B-Cell Screening

xPloration Maximizes Impact for OmniAb’s Partners through Efficient and Precise Mining of Immunized Antibody Repertoires OmniAb, Inc. &n...

May 14, 2025 | Wednesday | News
Exelixis Advances Invenra-Discovered XB628 into Phase 1 Clinical Trial for Solid Tumors

Invenra Inc., a biotechnology company specializing in the discovery and development of multispecific antibodies,  announced that its collaboration par...

May 14, 2025 | Wednesday | News
MaxisIT Evolves into Maxis AI, Launches Agentic AI Platform to Transform Clinical Trials

MaxisIT, a long-recognized provider of clinical data analytics platform for clinical trials, today announced its transformation into Maxis AI. This strat...

May 13, 2025 | Tuesday | News
Biocom California and KoreaBIO Sign MOU to Strengthen US-Korea Life Science Collaboration

Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade association which seeks to solid...

May 13, 2025 | Tuesday | News
Cytel Partners with Nested Knowledge to Launch AI-Powered Living Evidence Platform for HEOR and HTA

Cytel, a global leader in evidence generation and data-driven decision-making, today announced a partnership with Nested Knowledge, a pioneer in AI-power...

May 12, 2025 | Monday | News
UTR Therapeutics Files IND with FDA for UTRxM1-18 to Target c-MYC Driven Cancers with Ultra-Precise RNA Degradation

UTR Therapeutics Inc (UTRx Inc.), a drug development biotech company based in New York City, USA is pleased to announce a new milestone, the submission o...

May 12, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close